GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Gross Margin %

C21 Investments (XCNQ:CXXI) Gross Margin % : 40.00% (As of Oct. 2023)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. C21 Investments's Gross Profit for the three months ended in Oct. 2023 was C$3.78 Mil. C21 Investments's Revenue for the three months ended in Oct. 2023 was C$9.44 Mil. Therefore, C21 Investments's Gross Margin % for the quarter that ended in Oct. 2023 was 40.00%.


The historical rank and industry rank for C21 Investments's Gross Margin % or its related term are showing as below:

XCNQ:CXXI' s Gross Margin % Range Over the Past 10 Years
Min: 7.07   Med: 46.39   Max: 57.03
Current: 34.61


During the past 13 years, the highest Gross Margin % of C21 Investments was 57.03%. The lowest was 7.07%. And the median was 46.39%.

XCNQ:CXXI's Gross Margin % is ranked worse than
70.69% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.48 vs XCNQ:CXXI: 34.61

C21 Investments had a gross margin of 40.00% for the quarter that ended in Oct. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for C21 Investments was 0.00% per year.


C21 Investments Gross Margin % Historical Data

The historical data trend for C21 Investments's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Gross Margin % Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.07 34.84 53.93 57.03 46.39

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.17 23.46 35.36 39.53 40.00

Competitive Comparison of C21 Investments's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Gross Margin % distribution charts can be found below:

* The bar in red indicates where C21 Investments's Gross Margin % falls into.



C21 Investments Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

C21 Investments's Gross Margin for the fiscal year that ended in Jan. 2023 is calculated as

Gross Margin % (A: Jan. 2023 )=Gross Profit (A: Jan. 2023 ) / Revenue (A: Jan. 2023 )
=18 / 38.773
=(Revenue - Cost of Goods Sold) / Revenue
=(38.773 - 20.786) / 38.773
=46.39 %

C21 Investments's Gross Margin for the quarter that ended in Oct. 2023 is calculated as


Gross Margin % (Q: Oct. 2023 )=Gross Profit (Q: Oct. 2023 ) / Revenue (Q: Oct. 2023 )
=3.8 / 9.437
=(Revenue - Cost of Goods Sold) / Revenue
=(9.437 - 5.662) / 9.437
=40.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


C21 Investments  (XCNQ:CXXI) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

C21 Investments had a gross margin of 40.00% for the quarter that ended in Oct. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


C21 Investments Gross Margin % Related Terms

Thank you for viewing the detailed overview of C21 Investments's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (XCNQ:CXXI) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.
Executives
Bruce Macdonald Director

C21 Investments (XCNQ:CXXI) Headlines

No Headlines